Avantax Planning Partners, Inc. Hcw Biologics Inc. Put Options Transaction History
Avantax Planning Partners, Inc.
- $2.76 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding HCWB
# of Institutions
19Shares Held
3.13MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY2.02MShares$809,4650.01% of portfolio
-
Geode Capital Management, LLC Boston, MA182KShares$72,7820.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL181KShares$72,3240.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$52,7960.0% of portfolio
-
Pullen Investment Management, LLC Bradenton, FL75.1KShares$30,0460.03% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $14.3M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...